Scilex Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCILEX PHARMS
SCILEX PHARMS has three approved drugs.
There are twenty US patents protecting SCILEX PHARMS drugs.
Summary for Scilex Pharms
| US Patents: | 20 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Scilex Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scilex Pharms | ELYXYB | celecoxib | SOLUTION;ORAL | 212157-001 | May 5, 2020 | RX | Yes | Yes | 10,799,517 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Scilex Pharms | ZTLIDO | lidocaine | PATCH;TOPICAL | 207962-001 | Feb 28, 2018 | AB | RX | Yes | Yes | 10,765,640 | ⤷ Start Trial | Y | ⤷ Start Trial | ||
| Scilex Pharms | GLOPERBA | colchicine | SOLUTION;ORAL | 210942-001 | Jan 30, 2019 | RX | Yes | Yes | 10,383,821 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Scilex Pharms Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 3569227 | ⤷ Start Trial |
| Japan | 2018516266 | ⤷ Start Trial |
| World Intellectual Property Organization (WIPO) | 2017156392 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Scilex Pharms Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2488169 | C202330042 | Spain | ⤷ Start Trial | PRODUCT NAME: COCRISTAL DE TRAMADOL, OPCIONALMENTE EN FORMA DE UNA SAL FISIOLOGICAMENTE ACEPTABLE, Y CELECOXIB; NATIONAL AUTHORISATION NUMBER: 89051; DATE OF AUTHORISATION: 20230925; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): 89051; DATE OF FIRST AUTHORISATION IN EEA: 20230925 |
| 0731795 | 10075033 | Germany | ⤷ Start Trial | PRODUCT NAME: CELECOXIB; NAT. REGISTRATION NO/DATE: 48802.00.00 20000518; FIRST REGISTRATION: SE 14838 19991203 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
